{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T05:47:42Z","timestamp":1764308862004,"version":"build-2065373602"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.psyneuen.2013.10.008","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T12:24:34Z","timestamp":1382531074000},"page":"141-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Impact on cortisol and antidepressant efficacy of quetiapine and escitalopram in depression"],"prefix":"10.1016","volume":"39","author":[{"given":"Nina","family":"Sarubin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Nothdurfter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Schmotz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna-Maria","family":"Wimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Trummer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Lieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Uhr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Baghai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas C.","family":"Wetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"B\u00fchner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rainer","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelius","family":"Sch\u00fcle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"1994","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","key":"10.1016\/j.psyneuen.2013.10.008_bib0005"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/mp.2011.133","article-title":"Can adult neurogenesis buffer stress responses and depressive behaviour?","volume":"17","author":"Anacker","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0015","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/mp.2011.26","article-title":"Antidepressants increase human hippocampal neurogenesis by activating the glucocorticoid receptor","volume":"16","author":"Anacker","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jad.2008.12.016","article-title":"Efficacy, safety and tolerability of quetiapine augmentation in treatment resistant depression: an open-label, pilot study","volume":"117","author":"Anderson","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0025","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-1781(92)90027-Z","article-title":"Cortisol response to intramuscular desipramine in patients with major depression and normal control subjects: a replication study","volume":"44","author":"Asnis","year":"1992","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0030","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2042-6410-4-2","article-title":"Sex differences in stress-related receptors: \u201cmicro\u201d differences with \u201cmacro\u201d implications for mood and anxiety disorders","volume":"4","author":"Bangasser","year":"2013","journal-title":"Biol. Sex Differ."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0035","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jad.2010.08.032","article-title":"A pooled analysis of two randomised, placebo-controlled studies of extended release quetiapine fumarate adjunctive to antidepressant therapy in patients with major depressive disorder","volume":"127","author":"Bauer","year":"2010","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0040","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1172\/JCI115086","article-title":"Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications","volume":"87","author":"Brady","year":"1991","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jpsychires.2011.09.020","article-title":"Impact of citalopram on the HPA system. A study of the combined DEX\/CRH test in 30 unipolar depressed patients","volume":"46","author":"Bschor","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0050","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0055","first-page":"CD006532","article-title":"Escitalopram versus other antidepressive agents for depression","author":"Cipriani","year":"2009","journal-title":"CDS Rev."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0060","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4088\/JCP.08m04592","article-title":"Extended release quetiapine fumarate monotherapy in major depressive disorder: a placebo- and duloxetine-controlled study","volume":"70","author":"Cutler","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl. 4","key":"10.1016\/j.psyneuen.2013.10.008_bib0065","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00004850-199512004-00004","article-title":"The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission","volume":"10","author":"De Boer","year":"1995","journal-title":"Int. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0070","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/S1461145704004705","article-title":"Neuroendocrine effects of quetiapine in healthy volunteers","volume":"8","author":"De Borja Goncalves Guerra","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0075","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1176\/appi.ajp.157.8.1334","article-title":"Acute antidepressant effects of intravenous hydrocortisone and CRH in depressed patients: a double-blind, placebo-controlled study","volume":"157","author":"DeBattista","year":"2000","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0080","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00004714-199706000-00003","article-title":"Pulse-dosing and conventional application of doxepin: effects on psychopathology and hypothalamus-pituitary-adrenal (HPA) system","volume":"17","author":"Deuschle","year":"1997","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.psyneuen.2013.10.008_bib0085","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/s00213-006-0314-6","article-title":"Quetiapine plus SSRI in treatment-resistant depression: possible mechanisms","volume":"185","author":"Devarajan","year":"2006","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0090","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0447.1997.tb00374.x","article-title":"Dexamethasone augmentation in treatment-resistant depression","volume":"95","author":"Dinan","year":"1997","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0095","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1017\/S1461145710000015","article-title":"Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in major depressive disorder (MDD) in patients with an inadequate response to ongoing antidepressant treatment: a multicentre, randomized, double-blind, placebo-controlled study","volume":"13","author":"El-Khalili","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"8","key":"10.1016\/j.psyneuen.2013.10.008_bib0100","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1055\/s-0032-1312592","article-title":"Sex, stress, and mood disorders: at the intersection of adrenal and gonadal hormones","volume":"44","author":"Fern\u00e1ndez-Guasti","year":"2012","journal-title":"Horm. Metab. Res."},{"year":"1969","series-title":"Computer Science: A First Course","author":"Forsythe","key":"10.1016\/j.psyneuen.2013.10.008_bib0105"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0110","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-2003-38087","article-title":"Clinical outcome after trimipramine in patients with delusional depression \u2013 a pilot study","volume":"36","author":"Frieboes","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0115","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1358\/dot.1999.35.3.533849","article-title":"Quetiapine fumarate (Seroquel): a new atypical antipsychotic","volume":"35","author":"Goldstein","year":"1999","journal-title":"Drugs Today (Barc)."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1185\/03007999909114085","article-title":"Focus on quetiapine","volume":"15","author":"Green","year":"1999","journal-title":"Curr. Med. Res. Opin."},{"issue":"7","key":"10.1016\/j.psyneuen.2013.10.008_bib0125","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/14737175.2013.811901","article-title":"Second-generation antipsychotics in the treatment of major depressive disorder: current evidence","volume":"13","author":"Han","year":"2013","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0130","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0022-3956(02)00021-3","article-title":"The combined DEX-CRH test in treatment course and long-term outcome of major depression","volume":"36","author":"Hatzinger","year":"2002","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1176\/ajp.153.1.93","article-title":"Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects","volume":"153","author":"Heuser","year":"1996","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0140","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0893-133X(00)00159-7","article-title":"The corticosteroid receptor hypothesis of depression","volume":"23","author":"Holsboer","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0165-0327(00)00352-9","article-title":"Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy","volume":"62","author":"Holsboer","year":"2001","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0150","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0165-1781(91)90041-M","article-title":"Repeated administration of the combined dexamethasone-human corticotropin releasing hormone stimulation test during treatment of depression","volume":"38","author":"Holsboer-Trachsler","year":"1991","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0155","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0006-8993(02)03570-9","article-title":"Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism","volume":"956","author":"Ichikawa","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0160","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.pnpbp.2005.03.014","article-title":"The combined dexamethasone\/CRH test as a potential surrogate marker in depression","volume":"29","author":"Ising","year":"2005","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0165","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.biopsych.2006.07.039","article-title":"Combined dexamethasone\/corticotropin releasing hormone test predicts treatment response in major depression \u2013 a potential biomarker?","volume":"62","author":"Ising","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0170","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1046\/j.1365-2826.2001.00712.x","article-title":"Chronic antidepressant treatments decrease pro-opiomelanocortin mRNA expression in the pituitary gland: effects of acute stress and 5-HT(1A) receptor activation","volume":"13","author":"Jensen","year":"2001","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jagp.2013.01.010","article-title":"Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (Quetiapine XR) monotherapy in elderly patients with major depressive disorder","author":"Katila","year":"2012","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0180","first-page":"CD008121","article-title":"Second-generation antipsychotics for major depressive disorder and dysthymia","author":"Komossa","year":"2010","journal-title":"CDS Rev."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0185","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/sj.npp.1300280","article-title":"Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test","volume":"28","author":"Kunzel","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0190","first-page":"1","article-title":"Psychopharmaco-endocrinology and depression research","volume":"46","author":"Laakmann","year":"1988","journal-title":"Monogr. Gesamtgeb. Psychiatr. Psychiatry Ser."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0195","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/da.20740","article-title":"Efficacy and tolerability of extended release quetiapine fumarate monotherapy as maintenance treatment of major depressive disorder: a randomized, placebo-controlled trial","volume":"27","author":"Liebowitz","year":"2010","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4088\/JCP.08m04942gre","article-title":"A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II)","volume":"71","author":"McElroy","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0205","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/da.20275","article-title":"Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study","volume":"24","author":"McIntyre","year":"2007","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0210","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-3956(98)00003-X","article-title":"cAMP-dependent phosphorylation system after short and long-term administration of moclobemide","volume":"32","author":"Mori","year":"1998","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0215","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/sj.npp.1300475","article-title":"Comparison of the effects of citalopram and escitalopram on 5-Ht-mediated neuroendocrine responses","volume":"29","author":"Nadeem","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0220","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00004714-200304000-00008","article-title":"Clinical and neurobiological effects of tianeptine and paroxetine in major depression","volume":"23","author":"Nickel","year":"2003","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2007.03.055","article-title":"Allosteric effects of R- and S-citalopram on the human 5-HT transporter: evidence for distinct high- and low-affinity binding sites","volume":"567","author":"Plenge","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0230","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00213-006-0452-x","article-title":"Quetiapine augmentation in treatment-resistant depression: a naturalistic study","volume":"187","author":"Sagud","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0235","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1365-2826.2006.01516.x","article-title":"Neuroendocrinological mechanisms of actions of antidepressant drugs","volume":"19","author":"Schule","year":"2007","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0240","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00213-002-1148-5","article-title":"The influence of mirtazapine on anterior pituitary hormone secretion in healthy male subjects","volume":"163","author":"Schule","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0245","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00213-006-0382-7","article-title":"Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients","volume":"186","author":"Schule","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0250","doi-asserted-by":"crossref","first-page":"e4324","DOI":"10.1371\/journal.pone.0004324","article-title":"The combined dexamethasone\/CRH Test (DEX\/CRH test) and prediction of acute treatment response in major depression","volume":"4","author":"Schule","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0255","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1159\/000126180","article-title":"Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo","volume":"55","author":"Seckl","year":"1992","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0260","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1124\/jpet.300.3.1085","article-title":"Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment","volume":"300","author":"Stout","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.psyneuen.2013.10.008_bib0265","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/npp.2011.306","article-title":"Randomized, placebo-controlled trials of antidepressants for acute major depression: thirty-year meta-analytic review","volume":"37","author":"Undurraga","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0270","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1038\/npp.2010.30","article-title":"Gender-specific association of galanin polymorphisms with hpa-axis dysregulation, symptom severity, and antidepressant treatment response","volume":"35","author":"Unschuld","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.psyneuen.2013.10.008_bib0275","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/YIC.0b013e32834d6f91","article-title":"Efficacy of extended release quetiapine fumarate monotherapy in patients with major depressive disorder: a pooled analysis of two 6-week, double-blind, placebo-controlled studies","volume":"27","author":"Weisler","year":"2012","journal-title":"Int. Clin. Psychopharmacol."},{"year":"1997","series-title":"Strukturiertes Klinisches Interview f\u00fcr DSM-IV, Achse I: Psychische St\u00f6rungen. Interviewheft","author":"Wittchen","key":"10.1016\/j.psyneuen.2013.10.008_bib0280"},{"key":"10.1016\/j.psyneuen.2013.10.008_bib0285","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-3956(01)00013-9","article-title":"Cortisol response in the combined dexamethasone\/CRH test as predictor of relapse in patients with remitted depression. a prospective study","volume":"35","author":"Zobel","year":"2001","journal-title":"J. Psychiatr. Res."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453013003739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453013003739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:43:24Z","timestamp":1759682604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453013003739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":57,"alternative-id":["S0306453013003739"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2013.10.008","relation":{},"ISSN":["0306-4530"],"issn-type":[{"type":"print","value":"0306-4530"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact on cortisol and antidepressant efficacy of quetiapine and escitalopram in depression","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2013.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}